Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats

Basit Öğe Kaydı
dc.authorwosidFadillioglu, Ersin/K-3817-2019
dc.authorwosidErdogan, Hasan/AFN-9249-2022
dc.contributor.authorFadillioglu, E
dc.contributor.authorErdogan, H
dc.date.accessioned2024-08-04T20:13:17Z
dc.date.available2024-08-04T20:13:17Z
dc.date.issued2003
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe clinical use of doxorubicin (Dxr), an antineoplastic agent, is limited by its extensive toxicity which is mostly mediated by oxidant injury. We have studied the effect of erdosteine. a mucolytic drug showing antioxidant properties, in preventing Dxr-toxicity to improve future Dxr therapy. Male Sprague-Dawley rats were divided into four groups. The first group that underwent no medication was accepted as control groups the second group was treated with a single i.p. injection of Dxr (20 mg kg(-1) bwt.); the third group was treated with oral erdosteine alone (10 mg kg(-1) b.wt. day(-1) for 12 days): and in the last group erdosteine was administered starting before Dxr injection for 12 days. The thiobarbituric acid reactive substances (TBARS) level of Dxr group was higher in both plasma and erythrocyte than the other groups. In plasma and erythrocyte. the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were increased in Dxr plus erdosteine group in comparison with control group, and the activities of GSH-Px were increased in Dxr plus erdosteine group in comparison with Dxr group. The erythrocyte catalase (CAT) activity of Dxr plus erdosteine group was higher than control and Dxr groups. Plasma xanthine oxidase activities and nitric oxide (NO) levels were not significantly different between groups. however erythrocyte NO level of Dxr group was higher than control, In conclusion. Dxr administration resulted in increased lipid peroxidation in plasma as well as erythrocyte and erdosteine treatment helped to prevent oxidative injury by increasing antioxidant enzymes, especially SOD. GSH-Px and CAT, in rats. (C) 2003 Elsevier Science Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/S1043-6618(03)00010-0
dc.identifier.endpage322en_US
dc.identifier.issn1043-6618
dc.identifier.issn1096-1186
dc.identifier.issue4en_US
dc.identifier.pmid12644389en_US
dc.identifier.scopus2-s2.0-0037376343en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage317en_US
dc.identifier.urihttps://doi.org/10.1016/S1043-6618(03)00010-0
dc.identifier.urihttps://hdl.handle.net/11616/93506
dc.identifier.volume47en_US
dc.identifier.wosWOS:000182089300008en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAcademic Press Ltd- Elsevier Science Ltden_US
dc.relation.ispartofPharmacological Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectdoxorubicinen_US
dc.subjecterdosteineen_US
dc.subjectlipid peroxidationen_US
dc.subjectoxidantsen_US
dc.subjectantioxidantsen_US
dc.titleEffects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in ratsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu